LINC00886: A Potential Drug Target and Biomarker (G730091)

Target Name: LINC00886

NCBI ID: G730091

LINC00886

Other Name(s): Long intergenic non-protein coding RNA 886 | long intergenic non-protein coding RNA 886

LINC00886: A Potential Drug Target and Biomarker

Introduction

LINC00886 is a long intergenic non-protein coding RNA (lncRNA) with a unique structure and gene expression pattern. It has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. In this article , we will discuss the characterization of LINC00886, its potential drug targets, and its potential as a biomarker.

Characterization of LINC00886

LINC00886 is a 24.8 kb RNA molecule that is located between exons 11 and 12 of the X chromosome in human chromosome 17. It has a unique structure, with a 5' to 3' open reading frame (ORF) and a 3' to 5' exonic ORF. The ORF of LINC00886 contains 18 coding regions, including a unique start codon, a stop codon, and a middle intron.

Expression and Localization

LINC00886 is highly expressed in various tissues and organs, including brain, spleen, and pancreas. It is also expressed in various cell types, including neurons, glial cells, and immune cells. LINC00886 is primarily expressed in the brain, with the highest expression levels observed in the prefrontal cortical cortical tissue.

Drug Target Potential

LINC00886 has been identified as a potential drug target due to its unique structure and gene expression pattern. The 5' to 3' ORF of LINC00886 contains a highly conserved domain that is involved in various cellular processes, including cell signaling, DNA replication, and RNA translation. This domain is also known as the TARZ domain, which is a conserved region that is involved in various cellular processes, including DNA-protein interactions and RNA translation.

The 3' to 5' ORF of LINC00886 contains a unique gene expression pattern that is different from other lncRNAs. It is expressed in various tissues and cell types, including neurons, glial cells, and immune cells. It is also highly expressed in the brain , with the highest expression levels observed in the prefrontal cortical tissue. These observations suggest that LINC00886 may be a drug target that can be targeted by small molecules or antibodies that can modulate its expression levels.

Biomarker Potential

LINC00886 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. Its unique structure and gene expression pattern make it a promising candidate for biomarker research.

In cancer, LINC00886 has been identified as a potential biomarker for various types of cancer, including neuroendocrine tumors, germ cell tumors, and hematological tumors. Its expression levels have been observed to vary significantly between different types of cancer, which may be related to their clinical outcomes.

In neurodegenerative diseases, LINC00886 has been identified as a potential biomarker for various types of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. Its expression levels have been observed to vary significantly between different types of neurodegenerative diseases, which may be related to their clinical outcomes.

In psychiatric disorders, LINC00886 has been identified as a potential biomarker for various types of psychiatric disorders, including depression, anxiety, and schizophrenia. Its expression levels have been observed to vary significantly between different types of psychiatric disorders, which may be related to their clinical outcomes.

Conclusion

In this article, we have discussed the characterization of LINC00886, its potential drug target and biomarker potential. LINC00886 is a unique lncRNA that has a

Protein Name: Long Intergenic Non-protein Coding RNA 886

The "LINC00886 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC00886 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets